Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_assertion description "[In search for general PCR targets for minimal residual disease (MRD) studies in acute myeloid leukemia (AML), Wilms' tumor gene 1 (WT1) expression was assessed by real-time RT-PCR relative to the control gene ABL in 569 archived samples of AML patients (pts).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_assertion evidence source_evidence_literature NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_assertion SIO_000772 15920493 NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_assertion wasDerivedFrom befree-20140225 NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_assertion wasGeneratedBy ECO_0000203 NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP891377.RAl-5W-rsVI1m1B_D3qwEWws1V6_NSInqTsACYFrjD9Zo130_provenance.